Purchasing an Automated External Defibrillator (AED) can be a difficult decision with numerous manufacturers to choose from and numerous different features. Therefore, understanding the differences and capabilities of each AED is key to selecting the proper AED for your organization.
The HeartSine Samaritan PAD Automated External Defibrillator (AED) is a device that’s ideal for any organization. Not only is it the lightest (2.4 lbs) of all the AEDs on the market, but also the most durable. With an IP rating of 56 against dust and water, the HeartSine Samaritan can be exposed to various weather conditions which allows it to be taken virtually anywhere.
Unlike its competitors, the HeartSine Samaritan utilizes PAD-PAKs (adult & pediatric). These PAD-PAKs consist of one set of pad and a battery sealed together with one expiration date. Each PAD-PAK has a lifespan of 3.5 years , keeping the cost of replacement pads/batteries to a minimum. The PAD-PAKs also aviation ready, meaning the HeartSine Samaritan can be used during flight in the event someone experience sudden cardiac arrest (SCA).
The HeartSine Samaritan performs self tests daily, weekly, and monthly to ensure the AED is fully functional. The status indicator light will flash to let the responder know that this AED is rescue ready at any time. With clear voice prompts, the HeartSine Samaritan assists responders during an emergency and allowing the responder to bridge the gap until local EMS arrives. Not only does its lighted visual and audio display help guide the responder step by step, but this feature helps the responder understand what the next step should be. If a shock is needed, the “shock button” illuminates and should be pushed.
A key factor when deciding purchasing any electronic device is the manufacturer’s warranty. The HeartSine offers one of the longest warranties on the market, 7 years. The PAD-PAK itself has a 3 year warranty. The long warranty demonstrates the manufacturer’s extraordinary commitment to quality.
The HeartSine Samarian has the ability to record any event that occurs during its use. It will record the ECG trace and duration, shock delivery information, and the CPR intervals. This information can be downloaded to your computer using the HeartSine Data Cable. Furthermore, the USB data cable can also be used to update the Samaritan to the latest AHA Guidelines.
As you can see, there are many advantages to owning the Heartsine Samaritan. Below is a list of major business sectors that have found to Samaritan to be an ideal fit.
- Electric Companies
- Construction Companies
- School Districts
- Fortune 500 Companies
- Government Entities
- Churches
Contact HeartSafe America today to find out more about the HeartSine Samaritan PAD AED and how to implement your AED Program. HeartSafe America’s goal is to educate the public about Sudden Cardiac Arrest and how AEDs can increase the survival rate.
2 comments:
You talk about the Heartsine, but use medtronic CR+ picture... what is your opinion of the CR+
HeartSine hit with Class I over defibrillator recall
HeartSine launched a global recall of its Samaritan defibrillators after 5 deaths possibly related to a malfunction in the devices, and the FDA has slapped the affair with its most serious label, warning of serious injury or fatality.
In September, the Irish devicemaker launched a worldwide correction, warning customers that some Samaritan 300/300P models had been found to intermittently switch on and off, depleting the battery and possibly rendering them inoperable during a cardiac event. Furthermore, some devices have a software glitch that can misinterpret battery life and shut the unit off unnecessarily.
HeartSine says it hasn't received any reports of deaths tied directly to the malfunction, but it is investigating 5 fatalities that might be related. The FDA is asking patients and physicians to report adverse events through its online MedWatch system.
The company said it has sent backup power sources to affected customers, warning them to keep the reserves on hand should the device fail during a cardiac event.
The affected devices were manufactured between August 2004 and January 2011.
- read the FDA notice
Post a Comment